Introduction 

  Looking back on 2013 heparin market, although domestic enterprises gradually adapt to the "quality standards"  impacts on the industry, the industry still followed the previous year trend of flat sales and price reduction. During the first three quarters, heparin average exports price was $ 6,768.27 / kg; export volume was 74,795 kg which fell 5.17% over previous year; exports sales was 506 million U.S. dollars, down 10.36% over previous year. Market fluctuation and stringent international regulatory brought significant changes in the heparin supply chain. The China domestic enterprises have to raise funds to backward integrate to the upstream crude base for control over raw materials, as well as forward integrate to downstream formulation space into the high-end market, in order to be at a favorable position for the future competition.   

eChinaChem has been organizing the "Heparin 360 ° Summit Forum" for the past four years. The forum has attracted thousands of industry and academic professionals. eChinaChem will hold the fifth "2014 Heparin 360 ° Summit Forum", in July 7-8 2014 at Beijing to invite industry professionals once again convene together to discuss the future development of the industry and 360-degree supply chain gathering for discussion on the market trends and technology innovation! We sincerely welcome you to attend the summit together with domestic and foreign counterparts and experts to share experiences and get the newest information and the development of the industry, and thus promote China's scientific progress and technological innovation in the field.   

Market and Policy Session 

Analysis on China Heparin Import and Export of and Heparin International Market

• Data analysis on low molecular weight heparin species      classification and imported and domestic varieties

• Trends of Heparin International Market Prices and Supply  Chain Strategy

• Europe, USA, India and other emerging heparin market    overview

• New International Standard Certification, Drug Approval Procedures and Domestic Policy Interpretation

• Import and export declaration, license, permit process  interpretation   

Global Heparin Market Operation Trends and the Impacts on the Chinese Market

• Increasingly stringent domestic and international regulatory  policies impacts on heparin enterprises (USP36) 

• Low molecular weight heparin generic drugs and other  biochemical regulatory and policy developments 

• Heparin top products - fondaparinux sodium decanoate  liver chemical synthesis progress and industrialization  process    

  Technology and R&D Session 

Perspective and the strategy for Chinese heparin supply chain under new international environment

• Chinese companies progress to develop low molecular  weight heparin products

• Trends of the leading enterprises in the downstream  industry

• Advances in ultra-low molecular weight heparin and low  molecular weight products    

Heparin formulation and reagent production technology and future competitive position in the market

• Ultra-low molecular weight heparin and low molecular  weight formulation development

• Three low molecular weight heparin (enoxaparin,  dalteparin, nadroparin) structural modification    

New technology development in Heparin production

• Heparin production fermentation and purification technology  progress

• Technological progress on increasing crude yield and fine  purification research and development progress on the three

• low molecular weight heparin (enoxaparin, dalteparin,  nadroparin)

• Enzymatic method progress for removal of dermatan  impurities     

Application and Production Session 

Worldwide Heparin Applications Reviews

Market changes in structure anticoagulant drugs

Market performance heparin preparations    

Molecular Weight Distribution, Potency And Structural

Characterization Of Low Molecular Weight Heparin Varieties

Core Indicators Of Quality Control Applications     

• Source and quality testing injection of low molecular  weight materials    

Heparin Clinical Application And Research In The Field Of Cardiovascular And Cerebrovascular Diseases And Other New Developments

• Anticoagulant heparin and heparan comparative clinical  application of cancer

• Clinical efficacy and indications of low molecular weight  heparin  

• Low molecular weight heparin anticoagulant activity of non-  clinical applications

• Anti-inflammatory, anti-cancer, immune, regulating blood  lipids, protect endothelial cells

• Status heparin substitute product development and clinical  application of drugs   

Speakers

Ming Xu
Deputy President of CCCMHPIE

Huihong Fan
Deputy Chief of Biochemical Group, NICPBP

Shengli Ji
GM, Hebei Changshan Biochemical Pharmaceutical Co. Ltd.

Xinhui Xing
PhD. Tsinghua University

Zhenxing Zhang
Prof, Suzhou University

Xueming Xu
GM, Shanghai Seanpharma Co.,Ltd